CO4410189A1 - Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo - Google Patents

Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo

Info

Publication number
CO4410189A1
CO4410189A1 CO95029779A CO95029779A CO4410189A1 CO 4410189 A1 CO4410189 A1 CO 4410189A1 CO 95029779 A CO95029779 A CO 95029779A CO 95029779 A CO95029779 A CO 95029779A CO 4410189 A1 CO4410189 A1 CO 4410189A1
Authority
CO
Colombia
Prior art keywords
beta
alpha
epoxi
tax
tert
Prior art date
Application number
CO95029779A
Other languages
English (en)
Spanish (es)
Inventor
Jean Rene Authelin
Jacques Doveze
Bernadette Mandard
Isabelle Taillepied
Elise Fouque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4410189(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of CO4410189A1 publication Critical patent/CO4410189A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CO95029779A 1994-07-08 1995-07-07 Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo CO4410189A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408479A FR2722191B1 (fr) 1994-07-08 1994-07-08 Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle

Publications (1)

Publication Number Publication Date
CO4410189A1 true CO4410189A1 (es) 1997-01-09

Family

ID=9465183

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95029779A CO4410189A1 (es) 1994-07-08 1995-07-07 Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo

Country Status (38)

Country Link
US (1) US6022985A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0770070B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3753155B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100391753B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1067996C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE171702T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU706519B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9508789A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2193531C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO4410189A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ284695B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69505128T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0770070T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DZ (1) DZ1905A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2121404T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI119246B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2722191B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3027558T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU220634B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL114274A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN183947B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS2032B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA23606A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9700173A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY118481A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO314500B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ289455A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE8697A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL179876B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2126397C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI0770070T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK280520B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN95071A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW419473B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA51624C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY23991A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1996001815A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA955646B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049321A2 (en) 1997-04-28 1998-11-05 Rhone-Poulenc Rorer S.A. Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
US6853921B2 (en) 1999-07-20 2005-02-08 Halliburton Energy Services, Inc. System and method for real time reservoir management
US6266619B1 (en) * 1999-07-20 2001-07-24 Halliburton Energy Services, Inc. System and method for real time reservoir management
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US7584165B2 (en) * 2003-01-30 2009-09-01 Landmark Graphics Corporation Support apparatus, method and system for real time operations and maintenance
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
WO2005061474A1 (en) 2003-12-12 2005-07-07 Quiral Química Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
US7142986B2 (en) * 2005-02-01 2006-11-28 Smith International, Inc. System for optimizing drilling in real time
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
PT3311805T (pt) * 2005-08-31 2020-04-21 Abraxis Bioscience Llc Composições compreendendo agentes farmacêuticos pouco hidrossolúveis e agentes antimicrobianos
BRPI0615292A8 (pt) * 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
MX2008009308A (es) * 2006-01-20 2008-10-03 Landmark Graphics Corp Administracion del sistema de produccion dinamica.
US20100160653A1 (en) * 2006-03-21 2010-06-24 Dr. Reddy's Laboratories Ltd. Docetaxel polymorphs and processes
EP2094084A4 (en) * 2006-10-20 2010-01-13 Scinopharm Singapore Pte Ltd PROCESS FOR PREPARING CRYSTALLINE WATER-FREE DOCETAXEL
KR100868116B1 (ko) 2007-04-09 2008-11-10 한미약품 주식회사 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법
KR100878455B1 (ko) 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
WO2009006590A2 (en) * 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
ES2389518T3 (es) * 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel
EP2080763A1 (en) * 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
US8686165B2 (en) * 2009-11-04 2014-04-01 Emcure Pharmaceuticals Limited Process for preparation of taxane derivatives
KR101752944B1 (ko) 2010-05-03 2017-07-03 테이코쿠 팔마 유에스에이, 인코포레이티드 비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
SI2753355T1 (sl) 2011-09-08 2019-02-28 New York University Onkolitični virus herpesa simpleksa in njegove terapevtske uporabe
WO2013096455A1 (en) 2011-12-20 2013-06-27 Dana-Farber Cancer Institute, Inc. Methods for diagnosing and treating oncogenic kras-associated cancer
KR101809858B1 (ko) 2012-04-04 2017-12-15 할로자임, 아이엔씨 항-히알루로난 제제 및 종양-표적 탁산을 이용한 병용 치료
CA2874521A1 (en) 2012-05-24 2013-11-28 Dana-Farber Cancer Institute, Inc. Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
WO2014014518A1 (en) 2012-07-18 2014-01-23 Dana-Farber Cancer Institute, Inc. Methods for treating, preventing and predicting risk of developing breast cancer
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2014149871A1 (en) 2013-03-14 2014-09-25 Icahn School Of Medicine At Mount Sinai Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
WO2015050844A1 (en) 2013-10-01 2015-04-09 Dana-Farber Cancer Institute, Inc. Methods of treating cancer with atovaquone-related compounds
US10350264B2 (en) 2014-03-27 2019-07-16 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
MA39818A (fr) 2014-03-30 2017-02-08 Benevir Biopharm Inc Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
EP3307330B1 (en) 2015-06-15 2021-03-10 New York University Method of treatment using oncolytic viruses
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
MY118481A (en) 2004-11-30
AU2930595A (en) 1996-02-09
CA2193531C (fr) 2006-12-05
JP3753155B2 (ja) 2006-03-08
NO970007L (no) 1997-01-02
CZ284695B6 (cs) 1999-02-17
SI0770070T1 (en) 1998-12-31
FI970069A0 (fi) 1997-01-07
DE69505128T2 (de) 1999-04-01
UY23991A1 (es) 1995-09-20
IS4411A (is) 1997-01-07
ES2121404T3 (es) 1998-11-16
AU706519B2 (en) 1999-06-17
MX9700173A (es) 1997-04-30
DZ1905A1 (fr) 2002-02-17
TW419473B (en) 2001-01-21
KR970704721A (ko) 1997-09-06
PE8697A1 (es) 1997-03-26
IN183947B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2000-05-20
PL318195A1 (en) 1997-05-26
NZ289455A (en) 1997-12-19
ATE171702T1 (de) 1998-10-15
RU2126397C1 (ru) 1999-02-20
KR100391753B1 (ko) 2004-02-11
BR9508789A (pt) 1997-10-21
FI970069L (fi) 1997-01-07
PL179876B1 (pl) 2000-11-30
HU220634B1 (hu) 2002-03-28
MA23606A1 (fr) 1996-04-01
NO314500B1 (no) 2003-03-31
CA2193531A1 (fr) 1996-01-25
IL114274A0 (en) 1995-10-31
SK280520B6 (sk) 2000-03-13
JPH10502627A (ja) 1998-03-10
GR3027558T3 (en) 1998-11-30
FI119246B (fi) 2008-09-15
FR2722191A1 (fr) 1996-01-12
ZA955646B (en) 1996-02-21
CZ3597A3 (en) 1997-04-16
CN1151741A (zh) 1997-06-11
DK0770070T3 (da) 1999-03-01
DE69505128D1 (de) 1998-11-05
HU9700041D0 (en) 1997-02-28
EP0770070A1 (fr) 1997-05-02
CN1067996C (zh) 2001-07-04
IS2032B (is) 2005-08-15
NO970007D0 (no) 1997-01-02
US6022985A (en) 2000-02-08
WO1996001815A1 (fr) 1996-01-25
SK697A3 (en) 1997-06-04
UA51624C2 (uk) 2002-12-16
TNSN95071A1 (fr) 1996-02-06
IL114274A (en) 1999-04-11
EP0770070B1 (fr) 1998-09-30
HUT76833A (en) 1997-11-28
FR2722191B1 (fr) 1996-08-23

Similar Documents

Publication Publication Date Title
CO4410189A1 (es) Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo
CU22772A3 (es) Suplementos alimenticios que contienen flavonol
DE69213617D1 (de) Kombinierte Extruderkopf Anordnung zur Herstellung eines Dichtungsstreifens
CO4700286A1 (es) PROCEDIMIENTO DE PREPARACION DEL TRIHIDRATO DEL (2R,3S)-3- BENZOILAMINO-2-HIDROXI-3-FENILPROPIONATO DE 4,10-DIACETOXI- 2(alfa)-BENZOILOXI-5(beta),20-EPOXI-1,7(beta)-DIHIDROXI-9- OXO-TAX-11-EN 13(beta)-ILO
DK153225C (da) Dieselbraendstof
FR2514765B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK157035C (da) Biologisk ren mikroorganismestamme samt fremgangsmaade til fremstilling af et dyrkningsprodukt heraf til anvendelse som et hudpraeparat
IT1207299B (it) Uniforme di un letto catalizzaotre dispositivo per l'alimentazione con un gas di scarico da depurare.
FR2746108B1 (fr) Procede de concentration d'une solution telle que mouts de raisin a basse temperature et pression atmospherique
PH16452A (en) Composition containing cinnamycin and use thereof
ES2026507T3 (es) Procedimiento para la obtencion en continuo de compuestos alifaticos que contienen grupos carbalcoxi.
ECSP961646A (es) PROCESO DE PREPARACION DEL TRIHIDRATO DE (2R,3S)-3-BENZOYLAMINO - 2 - HIDROXI - 3 - FENIL-PROPIONATO DE 4, 10 - DIACETOXI - 2 a- BENZOYLOXI - 5ß, 20 - EPOXI- 1, 7ß - DIHIDROXI - 9 - OXO - TAX - 11 - EN - 13 ßYLE
PT73593A (fr) Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives
GB1553662A (en) Sterilization of fermentation media
BE818145A (fr) Nouveaux esters amino-ethyliques n-disubstitues de la raubasineet procede d'obtention.
ATE7500T1 (de) Verfahren zur herstellung neuer sauerstoffhaltiger heterocyclen.
IT1130943B (it) Coltura termofila anaeroba di produttore di alcool
TH20161A (th) กรรมวิธีการเตรียม 4-อะเซตทอกซี-2อัลฟา-เบนโซอิลออกซิ-5เบตา, 20-อีพอกซี-1, 7เบตา, 10เบตา-ไทรไธดรอกซี-9-ออกโซ-แทกซ์-11-เอ็น-13อัลฟา-อิล (2r, 3s)-3-เทอร์ท-บิวทอกซี-คาร์บอนิลอะมิโน-2-ไฮดรอกซิ-3-ฟีนิลโพรพิออเนต ไทรไฮเดรต
KR830004412A (ko) 밀디오 마이신의 제조법
JPS51121588A (en) Culture medium for identifying bacteria
JPS533585A (en) Preparation of l-serine
KR830008667A (ko) 투명한 젤스틱
JPS54163256A (en) Radial static pressure bearing for static pressure screw